📰 Cameron Wickham News
Page 2 - Cameron Wickham News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cameron Wickham. Real-time updates on events, politics, business and more.
September 25, 2023
Vaughan, Ontario--(Newsfile Corp. - September 25, 2023) - Delota Corp. (CSE: LOTA) (FSE: S62) ("Delota" or the "Company") a nicotine vape enterprise spearheading the smoke-free revolution in Canada and catering to adult consumers seeking alternatives to traditional combustible tobacco, is pleased to announce the listing of its common shares on the Frankfurt Stock Exchange under the trading symbol "S62". Delota's common shares are now dual-listed on the Canadian...
August 20, 2023
Baggies not swift enough and get chased down by Panthers
July 22, 2023
Jeparit Rainbow beat Edenhope Apsley, Pimpinio overcome KLU
May 12, 2023
Vaughan, Ontario--(Newsfile Corp. - May 12, 2023) - Delota Corp. (TSXV: LOTA) ("Delota" or the "Company"), an established Canadian vape and cannabis retailer, is pleased to announce that the Company has
February 4, 2023
The ownership of property in Australia is a matter of public record, but teasing out who is behind some real estate deals is not always straightforward.
October 20, 2022
Toronto, Ontario--(Newsfile Corp. - October 20, 2022) - Highvista Gold Inc. (TSXV: HVV.H) (the "Company") is pleased to announce effective immediately it has appointed Messrs. Cameron Wickham and Paul
June 6, 2022
Champion Gaming (TSX-V:WAGR) Group Inc. has announced a number of management and board changes, effective June 3, 2022, including a new chief executive...
June 3, 2022
Louisville, Kentucky--(Newsfile Corp. - June 3, 2022) - Champion Gaming Group Inc. (TSXV: WAGR) (formerly, Prime City One Capital Corp.) ("Champion Gaming" or the "Company") announced today a number of
February 15, 2022
Q BioMed Inc has outlined its strategic directions and goals for 2022 that call for increasing revenues as the biotech seeks to monetize its current...
February 14, 2022
Q BioMed Inc has outlined its strategic directions and goals for 2022 that call for increasing revenues as the biotech seeks to monetize its current...